Buy L&T with target of Rs 1600: Religare Capital
Suhas Harinarayanan, MD and co-head research, Religare Capital, says while there was a disbelief in the order inflow guidance, leading to tepid reaction in the stock. The brokerage says it’s guidance for the company remains unchanged.
